Evaluation of drug interaction software to identify alerts for transplant medications

Annals of Pharmacotherapy

Volumn 39, Issue 1, 2005, Pages 45-50

  Smith, Wendy D ^a,b   Hatton, Randy C ^a,c   Fann, Amy L ^a,c   Baz, Maher A ^d   Kaplan, Bruce ^d,e  

^a UNIVERSITY OF FLORIDA   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

^d UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^e NONE

Author keywords

Computerized physician order entry; Drug interaction software; Drug interactions; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS;

ARTICLE; BIOSAFETY; CALCULATION; COMPUTER PROGRAM; DATA BASE; ELECTRONICS; PHYSICIAN; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; STANDARDIZATION; TOXICITY; TRANSPLANTATION;

DATABASES; DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFORMATION SYSTEMS; MEDICATION ERRORS; PRESCRIPTIONS, DRUG; SENSITIVITY AND SPECIFICITY; SOFTWARE; TRANSPLANTATION;

EID: 11144222284     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E331     Document Type: Article

References (26)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999:182-5. www.nap.edu/books/0309068371/html/ (accessed 2004 June 16).
2. Healthcare leaders urge adoption of methods to reduce adverse drug events. News Release. National Patient Safety Partnership, May 12, 1999.
3. Kirle LE. Massachusetts Hospital Association (Massachusetts Coalition for the Prevention of Medical Errors). MHA best practice recommendations to reduce medication errors. www.macoalition.org/documents/ Best_Practice_Medication_Errors.pdf (accessed 2004 Dec 3).
4. Leape LL, Woods DD, Hatlie MJ, Kizer KW, Schroeder SA, Lundberg GD. Promoting patient safety by preventing medical error. JAMA 1998; 280:1444-7. DOI 10.1001/jama.280.16.1444
5. Consensus statement. American Society of Health-System Pharmacists. Top-priority actions for preventing adverse drug events in hospitals. Recommendations of an expert panel. Am J Health Syst Pharm 2003;53: 747-51.
6. Hazlet TK, Lee TA, Hansten PD, Horn JR. Performance of community pharmacy drug interaction software. J Am Pharm Assoc 2001;41:200-4.
7. Cavuto NJ, Woosley RL, Sale M. Pharmacies and prevention of potentially fatal drug interactions. JAMA 1996;275:1086-7.
8. Juurlink DN. Drug-drug interactions: where do we go from here? J Am Pharm Assoc 2004;44:128-34.
9. Glassman PA, Simon B, Belperio P, Lanto A. Improving recognition of drug interactions: benefits and barriers to using automated drug alerts. Med Care 2002;40:1161-71. DOI 10.1097/01.MLR.0000036429.31445.EO
10. Hansten PD, Horn JR, Hazlet TK. ORCA: OpeRational ClassificAtion of drug interactions. J Am Pharm Assoc 2001;41:161-5.
11. Payne TH, Nichol WP, Hoey P, Savarino J. Characteristics and override rates of order checks in a practitioner order entry system. Proceedings of the American Medical Informattus Association 2002;602-6.
12. Weingart SN, Toth M, Sands DZ, Aronson MD, Davis RB, Phillips RS. Physicians' decisions to override computerized drug alerts in primary care. Arch Intern Med 2003;163:2625-31. http://archinte.ama-assn.org/ cgi/reprint/163/21/ 2625 (accessed 2004 June 17).
13. Peterson JF, Bates DW. Preventable medication errors: identifying and eliminating serious drug interactions. J Am Pharm Assoc (Wash) 2001; 41:159-60.
14. Ferner RE. Computer aided prescribing leaves holes in the safety net. BMJ 2004;328:1172-3. DOI 10.1136/bmj.328.7449.1172
15. Magnus D, Rodgers S, Avery AJ. GP's views on computerized drug interactions alerts: questionnaire survey. J Clin Pharm Ther 2002;27:377-82.
16. Fulda TR, Valuck RJ, Vander Zanden J, Parker S, Byrns PJ. Disagreement among drug compendia on inclusion and ratings of drug-drug interactions. Curr Ther Res 2000;61:540-8.
17. Abarca J, Malone DC, Armstrong EP, Grizzle AJ, Hansten PD, Van Bergen RC, et al. Concordance of severity ratings provided in four drug interaction compendia. J Am Pharm Assoc 2004;44:136-41.
18. Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, et al. Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions. J Am Pharm Assoc (Wash) 2004;44:142-51.
19. Seifeldin R. Drug interactions in transplantation. Clin Ther 1995;17: 1043-61.
20. Levy GA. Long-term immunosuppression and drug interactions. Liver Transpl 2001;11(suppl 1):S53-9.
21. HealthRamp expands ePrescribing product via alliance with First DataBank. News Release. Wireless News, Copyright 2004. M2 Communications Ltd., August 7, 2004.
22. Banking on data. News Release. Health Data Management, Copyright 2003 American Banker-Bond Buyer, a division of Thomson Publishing Company Cooperation. Vol. 11(2);52.
23. First DataBank's prescriber order entry module reduces drug prescribing errors. News Release, PR Newswire, Copyright 2000. PR Newswire Association, Inc., May 24, 2000.
24. Hansten and Horn's drug interactions: analysis and management. St. Louis: Facts and Comparisons, April 2004.
25. Clinical pharmacology. Tampa, FL: Gold Standard Multimedia, 2004.
26. Fleiss JL. Statistical methods for rates and proportions. New York: Wiley & Sons, 1981.